FDA CLEARS LASER FOR TREATMENT OF UROLOGIC DISORDERS
FDA CLEARS LASER FOR TREATMENT OF UROLOGIC DISORDERS PALO ALTO, Calif., May 13 /PRNewswire/ -- Coherent Inc.
(NASDAQ: COHR)(Palo Alto) announced today that they are the first company to receive clearance from the Food and Drug Adminstration (FDA) for use of its VersaPulse(TM) holmium lasers in urology. The holmium laser uses miniature fibers which allow surgeons to convert major surgery to minimally invasive procedures, thus allowing shorter hospital stays and faster recovery.
The new laser procedures include the treatment of bladder tumors, urethral and ureteral strictures, condylomas, and lesions of the external genitalia, and bladder neck obstructions. Ted Belleza, director of marketing at Coherent, stated "Extensive clinical studies during the past two years have demonstrated the effectiveness of the new lasers in ablation, vaporization, incision, excision and coagulation of soft tissue encountered during urologic surgery." Two principal investigators conducted the pre-clinical studies that formed the basis of the FDA applications by Coherent: Douglas Johnson, M.D., professor of urology at the University of Texas M.D. Anderson Cancer Center, and George Fournier, M.D., assistant professor of medicine at the University of California in San Francisco. Johnson's work is summarized in a technical report to be presented at the conference of the American Society for Laser Medicine and Surgery which will be held in Orlando, Fla. next week. The VersaPulse holmium laser has truly become a multi-purpose, multi-specialty surgical tool. In 1990, the VersaPulse laser was cleared by the FDA for arthroscopic surgery in the knee, shoulder and other joints. Clearance for its use in open and endoscopic general surgery was issued in early 1991. Last September, VersaPulse was cleared for use in the treatment of lower-back disorders involving herniated disks. Other surgical specialties under active consideration include the use of VersaPulse in endoscopic sinus surgery and gynecology. Coherent Inc. is a worldwide leader in the development, manufacture and marketing of lasers and laser systems for medicine, science and industry. -0- 5/13/92 /CONTACT: Edwina DeRousse of Coherent, 415-852-3636/ (COHR) CO: Coherent Inc. ST: California IN: MTC SU:
MM -- SJ004 -- 9782 05/13/92 14:44 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||May 13, 1992|
|Previous Article:||CRAY RESEARCH ANNOUNCES NET EARNINGS EXPECTATIONS|
|Next Article:||COLUMBIA GAS TRANSMISSION CORPORATION GRANTED ADDITIONAL TIME TO FILE BANKRUPTCY REORGANIZATION PLAN|